US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gene Therapy: market research reports

Gene therapy is a technique used to treat or prevent diseases by the insertion, replacement reparation, regulation or removal of genes within an individual’s cells and biological tissues.

The most common approach to gene therapy is insertion, by which a functional gene is inserted into the genome to replace a disease-causing mutated gene.

Another method is modifying the gene sequence by substituting a mutated gene through homologous recombination. Selective reverse mutation is a type of gene therapy in which an abnormal gene is repaired and returned to its normal function. Gene regulation involves the “turning on or turning off” of a particular gene to alter its functionality.

Types of gene therapy include germ line gene therapy and somatic gene therapy. In germ-line gene therapy, germ cells (i.e. sperms or eggs) are modified by the insertion of functional genes. These genetic changes would be heritable and theoretically passed on to future generations. In somatic gene therapy, genes are transferred into somatic cells, effecting only the patient with no risk to passing on the altered genes to offspring.

RSS Feeds

Gene Therapy market research reports and industry analysis

< prev 1    
Gene Therapy in Oncology Drug Pipeline Update 2014
3/25/2014 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 96 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
$5,622.50
Virus-Like Particles (VLPs) Trends
1/1/2014 | published by: Global Industry Analysts
... the absence of viral genetic material. While lacking the DNA material, VLPs retain key immunological characteristics of viruses including particulate structures; repetitive surfaces; and capability to induce innate immunity by activating molecular-pattern pathogen-associated recognition receptors." ...  |  read more...
$950.00
The 2013-2018 Outlook for Gene Therapy in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,300 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
$495.00
Gene Therapy Partnering Terms and Agreements
7/1/2013 | published by: Current Partnering
... upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value The Gene Therapy Partnering Terms and Agreements report provides an understanding and access to the gene therapy ...  |  read more...
$1,795.00
The 2013 Report on Gene Therapy: World Market Segmentation by City
6/19/2013 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...  |  read more...
$795.00
Global Gene Therapy Market Analysis
6/1/2013 | published by: RNCOS
... the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market in spite of presenting few marketable products and being nascent in terms of revenue generation holds tremendous growth potential. As ...  |  read more...
$1,200.00
The 2013-2018 Outlook for Gene Therapy in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry ...  |  read more...
$495.00
Advances in Gene Therapy
3/25/2013 | published by: Datamonitor
... market outlook for the use of gene therapies in the treatment of rare monogenic diseases and common polygenic diseases. The potential threat to the protein therapy market is also assessed. Features and benefits Compares the ...  |  read more...
$3,500.00
Single-Use Technologies for Biopharmaceuticals: Global Markets
1/1/2013 | published by: BCC Research
... for 2012, and projections of compound annual growth rates (CAGRs) through 2017 In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, ...  |  read more...
$6,650.00
Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)
12/17/2012 | published by: MarketsandMarkets
... provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends. Global research and development Network, Innovation and Spin offs have been discussed. The ...  |  read more...
$4,650.00
Gene Therapy in Oncology Drug Pipeline Update 2012
10/16/2012 | published by: BioSeeker Group AB
... years amount to another 95 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 88 different targets. ...  |  read more...
$2,273.00
Cancer Bundle
8/1/2012 | published by: TriMark Publications
... Testing World Markets. Cancer Therapeutics Markets. Cancer Vaccines Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Game Changers in Breast Cancer Therapies. Molecular Diagnostics in Cancer Testing. Until ...  |  read more...
$26,010.00
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards
6/25/2012 | published by: GBI Research
... Failures, Close Regulatory Surveillance and High Compliance Standards”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global gene therapy market. The report analyzes technological aspects, advantages and disadvantages of various ...  |  read more...
$3,500.00
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications
6/12/2012 | published by: GBI Research
... CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications”, which provides insights into the global regenerative medicine therapeutics market. The report provides an in-depth analysis of regenerative medicine and the challenges in ...  |  read more...
$3,500.00
Neuroprotective Products: World Market Prospects 2012-2022
5/10/2012 | published by: Visiongain
... projected sales at overall world market, therapeutic submarket and product level to 2022. The protection of nerve tissues is becoming more important. You can assess the potential for drug revenues there, as well as finding ...  |  read more...
$2,633.00
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders
4/12/2012 | published by: GlobalData
... blood disorders such as beta-thalassemia and sickle cell anemia. An international team of researchers led by scientists at Weill-Cornell Medical College in New York City have designed a novel gene therapy strategy with potentially curative ...  |  read more...
$500.00
Gene Therapy
2/1/2012 | published by: Global Industry Analysts
... such as AnGes MG, Inc., BioSante Pharmaceuticals, GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based ...  |  read more...
$4,500.00
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships
9/12/2011 | published by: Espicom Healthcare Intelligence
An examination of trends and advances in the three major drug delivery sectors Unique sales forecasts to 2020 for key products Critical analyses of 58 specialist developers driving the drug delivery market onwards  |  read more...
$2,265.00
Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies
2/10/2011 | published by: GBI Research
... Stem Cell Therapies and Gene Therapies”, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection, Cardiovascular Disease and Oncology ...  |  read more...
$3,500.00
Gene Therapy
1/1/2011 | published by: Global Industry Analysts
... such as AnGes MG Inc., BioSante Pharmaceuticals, GenVec, Genzyme Corporation, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are ...  |  read more...
$4,500.00
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
12/1/2010 | published by: Kalorama Information
... other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience. Advanced Drug Delivery Markets ...  |  read more...
$2,500.00
Epigenetics: Current And Future Applications That Are Driving Novel Drug Discovery
8/25/2010 | published by: Espicom Healthcare Intelligence
This new 75+ page August 2010 report provides a complete briefing on the emerging importance of epigenetic research in drug and diagnostic development.  |  read more...
$1,215.00
Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
7/21/2010 | published by: MarketsandMarkets
... to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. ...  |  read more...
$4,650.00
Epigenetics
2/1/2010 | published by: Global Industry Analysts
... companies including many key and niche players worldwide such as Celgene Corporation, CellCentric Ltd., CellCentric Ltd., Epigentek Group, Inc., Genpathway, Inc., Merck & Co., Inc., MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion ...  |  read more...
$4,500.00
U.S. Epigenetics Markets
12/31/2009 | published by: Frost & Sullivan
... and chromatin immunoprecipitation segments. Each segment covers competitive structure, market share analysis, revenue forecasts, and product analysis. The key market drivers and restraints, challenges, strategies, and competitive factors are covered for the total market overview.  |  read more...
$6,000.00
< prev 1    
 
Our Clients